Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
D000328:Adult; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D001168:Arthritis / Q000209:etiology; D001769:Blood / Q000382:microbiology; D046508:Culture Techniques; D005076:Exanthema / Q000209:etiology; D005260:Female; D005334:Fever / Q000209:etiology; D006261:Headache / Q000209:etiology; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007668:Kidney; D008722:Methods; D010612:Pharyngitis / Q000209:etiology; D010614:Pharynx / Q000382:microbiology; D012409:Rubella / Q000276:immunology*; D012411:Rubella Vaccine / Q000009:adverse effects; D012412:Rubella virus / Q000302:isolation & purification; D014556:Urine / Q000382:microbiology; D014765:Viral Vaccines; D014776:Virus Cultivation; D005719:gamma-Globulins / Q000627:therapeutic use
D000906:Antibodies; D012411:Rubella Vaccine; D014765:Viral Vaccines; D005719:gamma-Globulins